# Imaging of Coronary Plaques in Participants Treated With Evolocumab

> **NCT03570697** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 164 (actual)

## Conditions studied

- Coronary Artery Disease (CAD)

## Interventions

- **DRUG:** Evolocumab
- **DRUG:** Placebo
- **DRUG:** Statin therapy

## Key facts

- **NCT ID:** NCT03570697
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-19
- **Primary completion:** 2020-12-18
- **Final completion:** 2021-01-21
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03570697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03570697, "Imaging of Coronary Plaques in Participants Treated With Evolocumab". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03570697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*